Community Health Nursing - Community Health, Immunisation & National Programmes MCQs with Answers

Answer: A. 0 - 5 yr children

Pulse Polio Immunization Programme in India targets all children below 5 years of age, irrespective of their previous vaccination status. The objective is to ensure no child under five remains
susceptible to poliovirus, thereby achieving eradication.
Explanation of options:
(a) 0 – 5 yr children: Correct. Covers every child below 5 years to break poliovirus transmission.
(b) 0 – 1 yr children: Incorrect. This age group is part of routine immunization, but Pulse Polio is not restricted to it.
(c) 1 – 5 yr children: Incorrect. If infants under 1 year are excluded, the programme goal would fail.
(d) 0 – 2 yr children: Incorrect. The programme covers beyond 2 years, up to 5 years.

Answer: D. Navjat Shishu Suraksha Karyakram

Rashtriya Bal Swasthya Karyakram: This program focuses on child health screening and early interventions.
Navjat Shishu Suraksha Karyakram: This program trains health personnel in basic newborn care and resuscitation.
IMNCI: Integrated Management of Neonatal and Childhood Illness addresses broader child health issues but does not focus specifically on newborn resuscitation.
Home-based newborn care: This involves postnatal care at home but does not train health personnel in resuscitation.

Answer: B. Covaxin

Covaxin: This is an inactivated whole virion vaccine, meaning it contains a killed form of the virus that cannot replicate but still triggers an immune response.
Covishield: It is a viral vector vaccine based on a modified chimpanzee adenovirus.
Moderna: This is an mRNA-based vaccine, not an inactivated virus.
Sputnik: Sputnik V is a viral vector vaccine using human adenoviruses, not an inactivated virus.

Answer: D. 16 January 2021

15 October 2021: This date is unrelated to the launch of COVAXIN.
18 December 2021: This date does not correspond to the rollout of COVID-19 vaccination in India.
16 January 2021: India launched its COVID-19 vaccination drive, including COVAXIN (developed by Bharat Biotech), on 16 January 2021. This marked the beginning of one of the world’s largest
vaccination campaigns.
22 November 2021: This date is unrelated to the initiation of COVID-19 vaccination in India.